Darunavir/Ritonavir clinical trials
How each study uses Darunavir/Ritonavir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
15 studies that test it; most in 2007 (3)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 3 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 10
Germans Trias i Pujol Hospital (2) · Community Research Initiative of New England (2) · St Stephens Aids Trust (2) · ViiV Healthcare (1) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (1) · Janssen-Cilag G.m.b.H (1) · University of California, San Francisco (1) · Janssen Pharmaceutica N.V., Belgium (1)
Often tested with
Tested in the same studies.
Etravirine (3) · Ritonavir (2) · Lopinavir-ritonavir drug combination (2) · Atazanavir (2) · Fosamprenavir (2) · Raltegravir (2) · GSK3640254 (1) · Nevirapine (1)
Related medicines
As reviewed, each with the page that says it.
- One of Protease Inhibitors source
Studies
Open first, then newest update. How each study uses Darunavir/Ritonavir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 15
- Drug-drug Interaction (DDI) Study of GSK3640254 With Darunavir/Ritonavir (DRV/RTV) and Etravirine (ETR)CompletedPhase 1ViiV HealthcareNCT04630002Written as Darunavir/Ritonavir (DRV/RTV)How we know
- Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIVCompletedPhase 1Germans Trias i Pujol HospitalNCT00307502Written as Darunavir/ritonavirHow we know
- Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected AdultsCompletedPhase 2Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsNCT00830804Written as Darunavir/RitonavirHow we know
- Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/rCompletedPhase 4Community Research Initiative of New EnglandNCT00756730Written as DRV/rHow we know
- Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease InhibitorsCompletedPhase 4Community Research Initiative of New EnglandNCT00543101Written as Darunavir (DRV/r)How we know
- Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)CompletedPhase 3Janssen-Cilag G.m.b.HNCT01516970Written as Darunavir/Ritonavir (DRV/r)How we know
- Interaction of Buprenorphine With HIV Medications and Tuberculosis MedicationsCompletedPhase 1University of California, San FranciscoNCT00877591Written as Darunavir/RitonavirHow we know
- Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-RegimensCompletedPhase 4Germans Trias i Pujol HospitalNCT00994344Written as Darunavir/ritonavirHow we know
- Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / LumefantrineCompletedPhase 1Janssen Pharmaceutica N.V., BelgiumNCT01876966Written as Darunavir/ritonavirHow we know
- Drug-Drug Interaction of Darunavir/Ritonavir on PitavastatinCompletedPhase 4Kowa Research Institute, Inc.NCT01422369Written as Darunavir/Ritonavir (Prezista)How we know
- Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe DrugsCompletedPhase 1GlaxoSmithKlineNCT00920088Written as darunavir/ritonavirHow we know
- Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant VirusesCompletedPhase 2French National Agency for Research on AIDS and Viral HepatitisNCT00460382Written as darunavir/ritonavirHow we know
- Double Protease Inhibitor to Darunavir Switch StudyCompletedPhase 4St Stephens Aids TrustNCT00531557Written as Darunavir ritonavirHow we know
- Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected PatientsStatus unknownPhase 4Fundación HuéspedNCT01013987Written as Darunavir/ritonavirHow we know
- Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected SubjectsCompletedPhase 1St Stephens Aids TrustNCT00765271Written as Darunavir/ritonavirHow we know
Given beside what is tested · 2 — Darunavir/Ritonavir is usual care or a partner of the new treatment
- Darunavir/Ritonavir + Lamivudine Versus Darunavir/Ritonavir +Emtricitabine/Tenofovir in Naïve HIV-1 Infected SubjectsCompletedPhase 4Fundación HuéspedNCT02770508Written as darunavir/ritonavirHow we know
- Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected SubjectCompletedPhase 4Fundacion SEIMC-GESIDANCT02159599Written as Darunavir/RitonavirHow we know